Common Contracts

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH and VERASTEM, INC. AMENDED AND RESTATED EXCLUSIVE PATENT LICENSE AND TANGIBLE...

Exclusive Patent License and Tangible Property Agreement • January 13th, 2012 • Verastem, Inc. • Pharmaceutical preparations • Massachusetts

• Contract Type
  Exclusive Patent License and Tangible Property Agreement
• Filed
  January 13th, 2012
• Company
  Verastem, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Massachusetts

This Amended and Restated Agreement (the “AGREEMENT”), effective as of January 11, 2012 (the “RESTATEMENT DATE”), is by and between the Whitehead Institute for Biomedical Research (“WHITEHEAD”), a Delaware corporation, with a principal office at Nine Cambridge Center, Cambridge, Massachusetts 02142, and Verastem, Inc. (“COMPANY”), a Delaware corporation, with a principal place of business at 215 First Street, Suite 440, Cambridge, MA 02142.

Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH And VERASTEM, INC. EXCLUSIVE PATENT LICENSE AND TANGIBLE PROPERTY AGREEMENT

Exclusive Patent License and Tangible Property Agreement • November 3rd, 2011 • Verastem, Inc. • Massachusetts

• Contract Type
  Exclusive Patent License and Tangible Property Agreement
• Filed
  November 3rd, 2011
• Company
  Verastem, Inc.
• Jurisdiction
  Massachusetts

This Agreement, effective as of October 13, 2010 (the “EFFECTIVE DATE”), is by and between the Whitehead Institute for Biomedical Research (“WHITEHEAD”), a Delaware corporation, with a principal office at Nine Cambridge Center, Cambridge, Massachusetts 02142, and Verastem, Inc. (“COMPANY”), a Delaware corporation, with a principal place of business at c/o Longwood Founders Fund, 800 Boylston Street, Suite 1555, Boston, Massachusetts 02199.